7,7-Diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one
CAS : 135911-02-3
Ref. 3D-FD157381
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
- (3aR,7aR)-2-[(1Z)-2-(2-methoxyphenyl)ethanimidoyl]-7,7-diphenyloctahydro-4H-isoindol-4-one
- (3aR,7aR)-Octahydro-2-(1-imino-2-(2-methoxyphenyl)ethyl)-7,7-diphenyl-4H-isoindol
- 4H-Isoindol-4-one, octahydro-2-[1-imino-2-(2-methoxyphenyl)ethyl]-7,7-diphenyl-, (3aR,7aR)-
- 4H-Isoindol-4-one, octahydro-2-[1-imino-2-(2-methoxyphenyl)ethyl]-7,7-diphenyl-, (3aR-cis)-
- Rp 67580
7,7-Diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one is a cyclase inhibitor that binds to the bradykinin B2 receptor. It has been shown to reduce the size of the bladder and inhibit the occurrence of hypertrophy in rats. 7,7-Diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one also shows antiinflammatory properties in rats by inhibiting prostaglandin synthesis. This drug is an enantiopure compound and it has been determined that its maximal response occurs when administered at a dose of 10 mg/kg.